|
1.
|
Lee AH and Glimcher LH: Intersection of
the unfolded protein response and hepatic lipid metabolism. Cell
Mol Life Sci. 66:2835–2850. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Basseri S and Austin RC: ER stress and
lipogenesis: a slippery slope toward hepatic steatosis. Dev Cell.
15:795–796. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Rutkowski DT, Wu J, Back SH, Callaghan MU,
Ferris SP, Iqbal J, Clark R, Miao H, Hassler JR, Fornek J, Katze
MG, Hussain MM, Song B, Swathirajan J, Wang J, Yau GD and Kaufman
RJ: UPR pathways combine to prevent hepatic steatosis caused by ER
stress-mediated suppression of transcriptional master regulators.
Dev Cell. 15:829–840. 2008. View Article : Google Scholar
|
|
4.
|
Ron D and Walter P: Signal integration in
the endoplasmic reticulum unfolded protein response. Nat Rev Mol
Cell Biol. 8:519–529. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Ji C: Dissection of endoplasmic reticulum
stress signaling in alcoholic and non-alcoholic liver injury. J
Gastroenterol Hepatol. 23:S16–S24. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Colgan SM, Tang D, Werstuck GH and Austin
RC: Endoplasmic reticulum stress causes the activation of sterol
regulatory element binding protein-2. Int J Biochem Cell Biol.
39:1843–1851. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Goldstein JL, DeBose-Boyd RA and Brown MS:
Protein sensors for membrane sterols. Cell. 124:35–46. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Nakayama H, Otabe S, Ueno T, Hirota N,
Yuan X, Fukutani T, Hashinaga T, Wada N and Yamada K: Transgenic
mice expressing nuclear sterol regulatory element-binding protein
1c in adipose tissue exhibit liver histology similar to
nonalcoholic steatohepatitis. Metabolism. 56:470–475. 2007.
View Article : Google Scholar
|
|
9.
|
Mendez-Sanchez N, Chavez-Tapia NC,
Zamora-Valdes and Uribe M: Adiponectin, structure, function and
pathophysiological implications in non-alcoholic fatty liver
disease. Mini Rev Med Chem. 6:651–656. 2006. View Article : Google Scholar
|
|
10.
|
Yamauchi T, Kamon J, Waki H, Terauchi Y,
Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N,
et al: The fat-derived hormone adiponectin reverses insulin
resistance associated with both lipoatrophy and obesity. Nat Med.
7:941–946. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Nakayama H, Otabe S, Yuan X, Ueno T,
Hirota N, Fukutano T, Wada N, Hashinaga T and Yamada K: Effects of
adiponectin transgenic expression in liver of nonalcoholic
steatohepatitis model mice. Metabolism. 58:901–908. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Awazawa M, Ueki K, Inabe K, Yamauchi T,
Kaneko K, Okazaki Y, Bardeesy N, Ohnishi S, Nagai R and Kadowaki T:
Adiponectin suppresses hepatic SREBP1c expression in an
AdipoR1/LKB1/AMPK dependent pathway. Biochem Biophys Res Commun.
382:51–56. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Shimomura I, Hammer RE, Richardson JA,
Ikemoto S, Bashmakov Y, Goldstein JH, Goldstein JL and Brown MS:
Insulin resistance and diabetes mellitus in transgenic mice
expressing nuclear SREBP-1c in adipose tissue: model for congenital
generalized lipodystrophy. Genes Dev. 12:3182–3194. 1998.
View Article : Google Scholar
|
|
14.
|
Otabe S, Yuan X, Fukutani T, Wada N,
Hashinaga T, Nakayama H, Hirota N, Kojima M and Yamada K:
Overexpression of human adiponectin in transgenic mice results in
suppression of fat accumulation and prevention of premature death
by high-calorie diet. Am J Physiol Endocrinol Metab. 293:E210–E218.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Matteoni CA, Younossi ZM, Gramlich T,
Boparai N, Liu YC and McCullough AJ: Nonalcoholic fatty liver
disease: a spectrum of clinical and pathological severity.
Gastroenterology. 116:1413–1419. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Hosogai N, Fukuhara A, Oshima K, Miyata Y,
Tanaka S, Segawa K, Furukawa S, Tochino Y, Komuro R, Matsuda M and
Shimomura I: Adipose tissue hypoxia in obesity and its impact on
adipocytokine dysregulation. Diabetes. 56:901–911. 2007. View Article : Google Scholar
|
|
17.
|
Frizzell N, Lima M and Baynes JW:
Succination of proteins in diabetes. Free Radic Res. 45:101–109.
2011. View Article : Google Scholar
|
|
18.
|
Ozcan U, Cao Q, Yilman E, Lee AH, Iwakoshi
NN, Ozdelen E, Görgün C, Glimcher LH and Hotamisligil GS:
Endoplasmic reticulum stress links obesity, insulin action, and
type 2 diabetes. Science. 306:457–461. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Wek RC and Anthony TG: Obesity: stressing
about unfolded proteins. Nat Med. 16:374–376. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Park SW, Zhou Y, Lee J, Lu A, Sun C, Chung
J, Ueki K and Ozcan U: The regulatory subunits of PI3K, p85α and
p85β, interact with XBP-1 and increase its nuclear translocation.
Nat Med. 16:429–437. 2010.
|
|
21.
|
Winnay JH, Boucher J, Mori MA, Ueki K and
Kahn R: A regulatory subunit of phosphoinositide 3-kinase increases
the nuclear accumulation of X-box-binding protein-1 to moderate the
unfolded protein response. Nat Med. 16:438–445. 2010. View Article : Google Scholar
|
|
22.
|
Van Herpen NA and Schrauwen-Hinderling VB:
Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol
Behav. 94:231–241. 2008.PubMed/NCBI
|
|
23.
|
Bugianesi E, Pagotto U, Manini R, Vanni E,
Gastaldelli A, de Lasio R, Pasquali R, Cassio A, Cicognani A and
Cacciari E: Plasma adiponectin in nonalcoholic fatty liver is
related to hepatic insulin resistance and hepatic fat content, not
to liver disease severity. J Clin Endocrinol Metab. 90:3498–3504.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Shu RZ, Zhang F, Wang F, Feng DC, Li XH,
Ren WH, Wu XL, Yang X, Liao XD, Huang L and Wang ZG: Adiponectin
deficiency impairs liver regeneration through attenuating STAT3
phosphorylation in mice. Lab Invset. 89:1043–1052. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Yoshiuchi K, Kaneko H, Matsuoka T, Kasami
R, Kohono K, Iwawaki T, Nakatani Y, Yamasaki Y, Shimomura I and
Matsuhisa M: Pioglitazone reduces ER stress in the liver: direct
monitoring of in vivo ER stress using ER stress-activated indicator
transgenic mice. Endocr J. 56:1103–1111. 2009. View Article : Google Scholar : PubMed/NCBI
|
